SCIESCOPUSQ1
Cancer Discovery
AMER ASSOC CANCER RESEARCH, United States
Cancer Discovery is an academic journal published by AMER ASSOC CANCER RESEARCH (United States). Identifiers: ISSN 2159-8274, eISSN 2159-8290. Indexed in SCIE, SCOPUS. Metrics: JIF 33.3, CiteScore 24.8, SJR 7.283, SNIP 4.12. Subject areas: ONCOLOGY. tlooto lists 2,770 papers from this journal.
CiteScore
24.80
Scopus の引用指標
SJR
7.283
SCImago 順位
SNIP
4.12
出典で正規化した影響度
パーセンタイル順位
-
JIF のパーセンタイル順位
ジャーナルプロフィール
- ISSN
- 2159-8274
- eISSN
- 2159-8290
- 略語
- CANCER DISCOV
- 出版社
- AMER ASSOC CANCER RESEARCH
- 国
- United States
Web of Science の分野
SCIEONCOLOGY
Scopus ASJC の分野
2730 Oncology
キーワード
Oncology
Papers in this journal
Recent papers
- Targeting KRAS codon 13 mutations using direct combination approaches in non-small cell lung cancer.
2026
- Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants
2026 · 2 citations
- Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical Cancer.
2026
- Testing Nature's Defenses: Inducing Cancer in the Naked Mole Rat.
2026
- Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 results.
2026
Most cited papers
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
2012 · 15,202 citations
- Hallmarks of Cancer: New Dimensions.
2022 · 6,410 citations
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy.
2018 · 2,484 citations
- AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer
2014 · 1,842 citations
- The emergence of lncRNAs in cancer biology
2011 · 1,749 citations